209 related articles for article (PubMed ID: 12947386)
21. BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis.
Abaji C; Cousineau I; Belmaaza A
Cancer Res; 2005 May; 65(10):4117-25. PubMed ID: 15899802
[TBL] [Abstract][Full Text] [Related]
22. A comparison of bilateral breast cancers in BRCA carriers.
Weitzel JN; Robson M; Pasini B; Manoukian S; Stoppa-Lyonnet D; Lynch HT; McLennan J; Foulkes WD; Wagner T; Tung N; Ghadirian P; Olopade O; Isaacs C; Kim-Sing C; Møller P; Neuhausen SL; Metcalfe K; Sun P; Narod SA
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1534-8. PubMed ID: 15941968
[TBL] [Abstract][Full Text] [Related]
23. Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
van Beers EH; van Welsem T; Wessels LF; Li Y; Oldenburg RA; Devilee P; Cornelisse CJ; Verhoef S; Hogervorst FB; van't Veer LJ; Nederlof PM
Cancer Res; 2005 Feb; 65(3):822-7. PubMed ID: 15705879
[TBL] [Abstract][Full Text] [Related]
24. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.
Werness BA; Ramus SJ; DiCioccio RA; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; Tsukada Y; Harrington P; Gayther SA; Ponder BA; Piver MS
Int J Gynecol Pathol; 2004 Jan; 23(1):29-34. PubMed ID: 14668547
[TBL] [Abstract][Full Text] [Related]
25. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.
Beetstra S; Salisbury C; Turner J; Altree M; McKinnon R; Suthers G; Fenech M
Carcinogenesis; 2006 Mar; 27(3):517-24. PubMed ID: 16162645
[TBL] [Abstract][Full Text] [Related]
26. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
27. BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
Thomassen M; Hansen TV; Borg A; Lianee HT; Wikman F; Pedersen IS; Bisgaard ML; Nielsen FC; Kruse TA; Gerdes AM
Acta Oncol; 2008; 47(4):772-7. PubMed ID: 18465347
[TBL] [Abstract][Full Text] [Related]
28. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997
[TBL] [Abstract][Full Text] [Related]
29. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
Dunn J; Potter M; Rees A; Rünger TM
Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
[TBL] [Abstract][Full Text] [Related]
30. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
[TBL] [Abstract][Full Text] [Related]
31. Exploiting the DNA repair defect in BRCA mutant cells in the design of new therapeutic strategies for cancer.
Tutt AN; Lord CJ; McCabe N; Farmer H; Turner N; Martin NM; Jackson SP; Smith GC; Ashworth A
Cold Spring Harb Symp Quant Biol; 2005; 70():139-48. PubMed ID: 16869747
[TBL] [Abstract][Full Text] [Related]
32. Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays.
Sadeghi F; Asgari M; Matloubi M; Ranjbar M; Karkhaneh Yousefi N; Azari T; Zaki-Dizaji M
Biol Proced Online; 2020; 22():23. PubMed ID: 33013205
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of DNA synthesis by ionizing radiation.
Jaspers NG; Zdzienicka MZ
Methods Mol Biol; 1999; 113():535-42. PubMed ID: 10443449
[No Abstract] [Full Text] [Related]
34. Homologous Recombination Deficiency in Breast Cancer: A Clinical Review.
den Brok WD; Schrader KA; Sun S; Tinker AV; Zhao EY; Aparicio S; Gelmon KA
JCO Precis Oncol; 2017 Nov; 1():1-13. PubMed ID: 35172494
[No Abstract] [Full Text] [Related]
35. Targeting BRCA-mutated tumors in mitosis.
Menolfi D; Zha S
Nat Cancer; 2021 Dec; 2(12):1296-1297. PubMed ID: 35121918
[No Abstract] [Full Text] [Related]
36. Combined Treatment Modalities for High-Energy Proton Irradiation: Exploiting Specific DNA Repair Dependencies.
Deycmar S; Pruschy M
Int J Part Ther; 2018; 5(1):133-139. PubMed ID: 31773025
[TBL] [Abstract][Full Text] [Related]
37. Exceptional Response to Dacarbazine in Uterine Leiomyosarcoma With Homozygous
Ingham MA; McGuinness JE; Kalinsky K; Schwartz GK
JCO Precis Oncol; 2018 Nov; 2():1-6. PubMed ID: 35135137
[No Abstract] [Full Text] [Related]
38. Correction: Functional
Meijer TG; Verkaik NS; Sieuwerts AM; van Riet J; Naipal KAT; van Deurzen CHM; den Bakker MA; Sleddens HFBM; Dubbink HJ; den Toom TD; Dinjens WNM; Lips E; Nederlof PM; Smid M; van de Werken HJG; Kanaar R; Martens JWM; Jager A; van Gent DC
Clin Cancer Res; 2019 May; 25(9):2935. PubMed ID: 31043383
[No Abstract] [Full Text] [Related]
39. An Unsolved Mystery.
Hospital (Lond 1886); 1920 Jul; 68(1780):400. PubMed ID: 29829696
[No Abstract] [Full Text] [Related]
40. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage.
Yoshida K; Miki Y
Cancer Sci; 2004 Nov; 95(11):866-71. PubMed ID: 15546503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
